Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

Nova Scotia Health’s QEII Health Sciences Centre is the first health centre in Canada to acquire a StarGuide SPECT/CT scanner by GE HealthCare
News | SPECT Imaging
QEII Health Sciences Centre First in Canada to Acquire StarGuide Hybrid SPECT/CT Nuclear Medicine Scanner Through GE HealthCare

June 3, 2024 — Nova Scotia Health’s QEII Health Sciences Centre is the first health centre in Canada to acquire a ...

Time June 03, 2024
arrow
Registration is now open for #ASTRO24
News
American Society for Radiation Oncology (ASTRO) to Host Annual Meeting in Washington, DC, Sept. 29-Oct. 2

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
177Lutetium-labeled radiohybrid Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is in development as a highly optimized, next generation therapeutic radiopharmaceutical
News | Radiopharmaceuticals and Tracers
Blue Earth Therapeutics Announces Promising Results from Preclinical Evaluation of Synergistic Drug Combinations with Radiopharmaceutical 177Lu-rhPSMA-10.1 for Treatment of Prostate Cancer

April 10, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time April 10, 2024
arrow
Ga-68 has a very short half-life, which presents logistical challenges in distribution
News | Radiopharmaceuticals and Tracers
RLS Radiopharmacies Partners with Eckert and Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
During the blood pool phase, it significantly shortens the T1 and T2 relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and dark blood effects in T2/T2*-weighted imaging. In the delay phase, by the local aggregation of ferumoxytol disrupting the uniformity of the local magnetic field, the decrease of the transverse magnetization vector Mxy is expedited, resulting in a negative contrast effect.
News | Molecular Imaging
Exploring Ferumoxytol: A Frontier in MRI Contrast Agents

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
First reported clinical results from independent clinical experience by University of Augsburg demonstrated encouraging preliminary data for 177Lu-rhPSMA-10.1
News | Radiopharmaceuticals and Tracers
Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients
News | Radiopharmaceuticals and Tracers
PanTera signs agreement with Bayer for the supply of actinium-225

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
(A) PET images of [68Ga]Ga-DOTA-ZCAM241 uptake at baseline and 3, 7, and 12 days after injection as inflammatory arthritis developed in single representative individual mouse. Images are normalized to SUV of 0.5 for direct comparison between time points. (B) CD69 immunofluorescence Sytox (Thermo Fisher Scientific) staining of joints of representative animals during matching time points.
News | PET Imaging
New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
Videos | RSNA
VIDEO: Advancements and Trends in Medical Imaging

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about ...

Time February 07, 2024
arrow
Under the new agreement, NorthStar will manufacture and distribute patient doses for ongoing Curadh Ac-225 clinical studies and provide Ac-225 for commercial use upon NorthStar’s submission of a Type II Drug Master File (DMF) to the FDA
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

January 5, 2024 — NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and ...

Time January 05, 2024
arrow
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway (gadopiclenol) in the European Union
News | Contrast Media
The European Commission Grants Marketing Authorization to Bracco Imaging for Vueway (gadopiclenol) Contrast Agent in the European Union

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...

Time December 11, 2023
arrow
Comprehensive program focused on innovation in AI – hosted jointly by teams from Calantic Digital Solutions and Blackford Analysis
News | Contrast Media
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation

November 29, 2023 — Bayer continues to advance its comprehensive Radiology portfolio with progress in the development ...

Time November 29, 2023
arrow
Leaders in radiology will share insights on VUEWAY (gadopiclenol) solution for injection after the first year of use in the US
News | Contrast Media
Bracco Diagnostics Showcases Innovation and Collaborative Vision at RSNA 2023 Annual Meeting

November 13, 2023 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic ...

Time November 13, 2023
arrow
A biomarker of norepinephrine deficiency in the heart may help to detect Lewy body diseases before symptoms appear
News | PET Imaging
PET Scans May Predict Parkinson’s Disease and Lewy Body Dementia in At-risk Individuals

November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...

Time November 08, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute of Aging (NIA)-sponsored multicenter study called the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).
News | PET Imaging
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the NIA-sponsored CLARiTI Trial

November 6, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute ...

Time November 06, 2023
arrow
Elekta wins public tender to deliver several Harmony linear accelerators to help meet demand for cancer treatments
News | Linear Accelerators
Elekta Continues to Support Ukrainian Cancer Patients with Latest Radiation Therapy Equipment

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
Comprehensive restoration of legacy machine offers the opportunity for sustainable solution
News | Proton Therapy
IBA Plans Total System Restoration on its First-ever Proton Therapy Installation

October 23, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...

Time October 23, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4
News | Radiopharmaceuticals and Tracers
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...

Time October 20, 2023
arrow
New company will advance Actinium-225 technologies
News | Radiopharmaceuticals and Tracers
ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

October 18, 2023 —ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian ...

Time October 18, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now